Celladon (Nasdaq: CLDN) 43.2% LOWER; confirmed its plans to suspend further research or development of its MYDICAR (AAV1/SERCA2a) program and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

FBR Capital Raises Price Target on Finish Line (FINL) Following 1Q16 EPS Beat June 29, 2015 11:06 AM UBS Raises Price Target on Finish Line (FINL) Following F1Q Results June 29, 2015 8:57 AM Jefferies Raises the Price Target on Finish Line (FINL) Following Managements Call to Action June 29, 2015 8:02 AM Piper Jaffray Raises Price Target on Finish Line (FINL) Following Q1 EPS Beat June 26, 2015 1:20 PM UBS Raises Price Target on Nike (NKE) Following EPS Beat June 26, 2015 10:15 AM UBS 'Disappointed' with Micron Technology (MU); Cuts Price Target to $27 June 26, 2015 9:58 AM